Global Cardiovascular Monitoring & Diagnostic Devices Market (2011 - 2016)

• Publication date: November 2011

Description OBJECTIVES OF THE RESEARCH Defining and measuring Global Cardiovascular Monitoring and Diagnostic devices market with respect to products, services and technologies To analyze the market structure by figuring out diverse sub-segments of the Global Cardiovascular Monitoring and Diagnostic devices market Forecast revenues of the Global Cardiovascular Monitoring and Diagnostic Devices market and its div...

Description

OBJECTIVES OF THE RESEARCH

Defining and measuring Global Cardiovascular Monitoring and Diagnostic devices market with respect to products, services and technologies
To analyze the market structure by figuring out diverse sub-segments of the Global Cardiovascular Monitoring and Diagnostic devices market
Forecast revenues of the Global Cardiovascular Monitoring and Diagnostic Devices market and its diverse submarkets with respect to twelve main geographies of the U.S., Canada, the U.K., Germany, France, Italy, Spain, Japan, Australia, China, India and Brazil
Recognizing the major market tendency and features driving or hindering growth of the global Cardiovascular Monitoring and Diagnostic devices market and its diverse submarkets
Strategically analyze each submarket with respect to individual growth trends and contribution to the overall Cardiovascular Monitoring and Diagnostic devices market
Analyze opportunities in the market for stakeholders by identifying high-growth segments of the global Cardiovascular Monitoring and Diagnostic devices market
Follow and evaluate competitive growth like alliances, joint ventures, mergers and acquisitions in the global Cardiovascular Monitoring and Diagnostic devices industry.


REPORT DESCRIPTION
Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. It also includes the devices such as interventional cardiology, cardiac rhythm management, cardiac assist devices, peripheral vascular devices, cardiac surgery, devices used to monitor cardiac events and cardiac prosthetic devices to record the electrophysiological impulses of the heart and to analyze and diagnose any abnormality related to the cardiac function.

Cardiovascular Monitoring and Diagnostic devices are used to detect and provide feedback of abnormal episodes of electrical functioning of the heart. The Cardiovascular Monitoring & Diagnostic devices include Holter and event recorders, ECG recorders and ECG stress testing.

This report analyses the Cardiovascular Monitoring and Diagnostic devices into four sub- categories, which includes:
ECG monitoring equipment is used to record the Electrocardiogram, ECG which are the intrinsic electrical signals generated in the heart.
ECG stress test or Tread Mill Test (TMT) is a diagnostic device used to record the ECG by subjecting the heart to excessive workload. These systems measure the performance of the heart at various stress levels and help physicians in disease diagnosis and deciding treatment protocol.
Event monitors or recorders are devices used to record only the abnormal events of the ECG over an extended period of time.
Holter monitors are devices used to record the ECG for a 24-hour period and to identify abnormal episodes of the ECG.

The report forecasts all the sub-categories by regional markets. It also identifies and analyzes the market trends, drivers, inhibitors and opportunities present in each. The key players and their growth strategies have also been analyzed and explained in the report.

SCOPE OF THE REPORT
The report categorizes global Cardiovascular Monitoring and Diagnostic devices market into four main subcategories: ECG Monitoring Devices, Holter Monitoring Devices, ECG Stress Testing Devices, and Event Monitoring Devices. In addition to market sizes and forecasts, the report identifies and analyzes trends and opportunities for each of the twelve submarkets; providing 48 market tables for submarkets in the U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, Australia, China, India and Brazil.

RESEARCH METHODOLOGY
Key market players were identified using Transparency Market Research, while market sizes were calculated using the bottom-up approach with market trends and penetration percentages verified through various research reports, analysts’ articles, previously published reports on the industry and key competitor companies investor presentations. We also analyzed the annual reports of key players and used their revenues for market estimations.

Global Cardiovascular Devices Industry

Table Of Content

CHAPTER 1 INTRODUCTION
1.1 OBJECTIVES OF THE RESEARCH
1.2 REPORT HIGHLIGHTS
1.3 SCOPE OF THE REPORT
1.4 RESEARCH METHODOLOGY
CHAPTER 2 CARDIOVASCULAR DEVICE MARKET
2.1 INTRODUCTION
2.1.1 CARDIOVASCULAR DISEASE & DEVICES – DEFINITION
2.1.2 HISTORY OF CARDIOVASCULAR DEVICES
2.2 CARDIOVASCULAR DEVICE & DIAGNOSIS MARKET
2.3 CARDIOVASCULAR DISEASE
2.3.1 CARDIOVASCULAR OPERATIONS & PROCEDURES
CHAPTER 3 CARDIOVASCULAR MONITORING & DIAGNOSTIC DEVICES
3.1 BACKGROUND
3.2 NEED FOR CARDIOVASCULAR MONITORING & DIAGNOSTIC DEVICES
3.2.1 IMPROVING STANDARDS OF CARE IN HIGH RISK SURGERY
3.2.2 REDUCING ADVERSE EVENTS
3.2.3 REDUCING COSTS
3.3 CURRENT TECHNOLOGIES & MARKET TRENDS
3.4 CARDIOVASCULAR MONITORING & DIAGNOSTIC DEVICES, MARKET SEGMENTATION
3.4.1 ECG MONITORING EQUIPMENT
3.4.2 HOLTER MONITOR
3.4.3 STRESS TESTING
3.4.4 CARDIAC MONITOR
3.4.4.1 Preparation
3.4.4.2 Aftercare
3.4.4.3 Normal results

CHAPTER 4 GLOBAL CARDIOVASCULAR MONITORING & DIAGNOSTIC DEVICES MARKET
4.1 INTRODUCTION
4.2 CARDIOVASCULAR MONITORING & DIAGNOSTIC DEVICES MARKET IN THE UNITED STATES
4.2.1 HEALTHCARE OVERVIEW
4.2.2 THE U.S. CARDIOVASCULAR DISEASE PREVALENCE & MORTALITY RATES
4.3 CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES IN THE U.K.
4.4 CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES IN GERMANY
4.5 CARDIOVASCULAR MONITORING & DIAGNOSTIC DEVICES IN FRANCE
4.6 CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES IN ITALY
4.7 CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES IN SPAIN
4.8 CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES IN JAPAN
4.9 CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES IN CHINA
4.10 CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES IN INDIA
4.11 CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES IN AUSTRALIA
4.12 CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES IN BRAZIL
4.13 CARDIOVASCULAR MONITORING AND DIAGNOSTIC DEVICES IN CANADA
CHAPTER 5 GROWTH DRIVERS & MARKET TRENDS
5.1 GROWTH DRIVERS
5.1.1 AGEING POPULATION
5.1.2 RISING CASES OF CARDIOVASCULAR DISEASES & GROWING AWARENESS
5.1.3 FAVORABLE REIMBURSEMENT APPROVALS
5.1.4 GROWTH IN INNOVATIVE TECHNOLOGY PRODUCTS.
5.2 MARKET TRENDS
5.2.1 NEW PRODUCT INNOVATION PIONEERED BY ADVANCED TECHNOLOGY
5.2.2 CRM MARKET POISED TO GROWTH
5.2.3 INDUSTRY CONSOLIDATION THROUGH INCREASING NUMBER OF MERGERS & ACQUISITIONS
5.2.4 GROWTH OF WIRELESS REMOTE FOLLOW-UP CAPABILITIES
CHAPTER 6 PRODUCT PIPELINE ANALYSIS
6.1 CARDIO3KG
6.2 CARDIOBIP
6.3 SIGNALIFE FIDELITY 200/FIDELITY 350/FIDELITY 400
6.4 FLOWWAVE 1000
6.5 ESO HEART MONITORING DEVICE
6.6 HEART VITAL SIGNS (HVS)
6.7 HF PRESSURE MEASUREMENT SYSTEM
6.8 SCHILLER AG’S NEW PRODUCT LINE (BASED ON HYPERQTM TECHNOLOGY)
6.9 REMONTM IMPRESSURE
6.10 GUARDIAN CARDIAC MONITOR AND ALERT SYSTEM DEVICE
6.11 VENTRIPOINT'S VMS(TM) DIAGNOSTIC TOOL
CHAPTER 7 MERGERS & ACQUISTIONS IN THE CARDIOVASCULAR MONITORING SPACE
7.1 FEB 2007 - CARDIONET ANNOUNCED ACQUISITION OF PDS HEART
7.2 NOV 2010 – CARDIONET ACQUIRED BIOTEL
7.3 OCT 2010 - OPTO CIRCUITS TO ACQUIRE CARDIAC SCIENCE
7.4 JUNE 2009 - SONOSITE ANNOUNCED PLANS TO ACQUIRE CARDIODYNAMICS
7.5 NOV 2010 - ST. JUDE MEDICAL INVESTED $60M IN CARDIOMEMS
CHAPTER 8 KEY COMPETITORS PROFILES
8.1 GE HEALTHCARE
8.1.1 BUSINESS OVERVIEW
8.1.2 SEGMENTS
8.1.3 KEY PRODUCTS
8.1.4 KEY DEVELOPMENTS
8.2 PHILIPS HEALTHCARE
8.2.1 BUSINESS OVERVIEW
8.2.2 SEGMENTS
8.2.3 KEY PRODUCTS
8.3 NIHON KOHDEN
8.3.1 BUSINESS OVERVIEW
8.3.2 SEGMENTS
8.3.3 KEY PRODUCTS
8.3.4 KEY DEVELOPMENTS
8.4 SCHILLER AG
8.4.1 BUSINESS OVERVIEW
8.4.2 SEGMENTS
8.4.3 KEY PRODUCTS
8.5 OPTO CIRCUITS (INDIA) LIMITED
8.5.1 BUSINESS OVERVIEW
8.5.2 SEGMENTS
8.5.3 KEY PRODUCTS
8.5.4 KEY DEVELOPMENTS
8.6 WELCH ALLYN
8.6.1 BUSINESS OVERVIEW
8.6.2 KEY PRODUCTS & DEVELOPMENTS
8.7 OSI SYSTEMS
8.7.1 BUSINESS OVERVIEW
8.7.2 SEGMENTS AND KEY PRODUCTS
8.7.3 KEY DEVELOPMENTS
8.8 FUKUDA DENSHI CO LTD.
8.8.1 BUSINESS OVERVIEW
8.8.2 SEGMENTS
8.8.3 KEY PRODUCTS
8.8.4 KEY DEVELOPMENTS
8.9 LIDCO GROUP PLC
8.9.1 BUSINESS OVERVIEW
8.9.2 SEGMENTS
8.9.3 KEY PRODUCTS
8.9.4 KEY DEVELOPMENTS
8.10 ST. JUDE MEDICAL INC
8.10.1 BUSINESS OVERVIEW
8.10.2 SEGMENTS
8.10.3 KEY PRODUCTS
8.10.4 KEY DEVELOPMENTS
8.11 JOHNSON & JOHNSON
8.11.1 BUSINESS OVERVIEW
8.11.2 SEGMENTS
8.11.3 KEY PRODUCTS
8.12 BIOTRONIK INC
8.12.1 BUSINESS OVERVIEW
8.12.2 SEGMENTS
8.12.3 KEY PRODUCTS
8.12.4 KEY DEVELOPMENTS
8.13 DRAGER MEDICAL GMBH
8.13.1 BUSINESS OVERVIEW
8.13.2 SEGMENTS
8.13.3 KEY PRODUCTS
8.13.4 KEY DEVELOPMENTS
8.14 EDWARDS LIFESCIENCES CORPORATION
8.14.1 BUSINESS OVERVIEW
8.14.2 SEGMENTS
8.14.3 KEY PRODUCTS
8.14.4 KEY DEVELOPMENTS
8.15 MEDTRONIC INC
8.15.1 BUSINESS OVERVIEW
8.15.2 SEGMENTS
8.15.3 KEY PRODUCTS
8.15.4 KEY DEVELOPMENTS
8.16 OMRON HEALTHCARE
8.16.1 BUSINESS OVERVIEW
8.16.2 SEGMENTS
8.16.3 KEY PRODUCTS
8.17 BMEYE B.V.
8.17.1 BUSINESS OVERVIEW
8.17.2 SEGMENTS
8.17.3 KEY PRODUCTS
8.17.4 KEY DEVELOPMENTS